Nautilus Advisors LLC Bristol Myers Squibb CO Transaction History
Nautilus Advisors LLC
- $136 Billion
- Q2 2025
A detailed history of Nautilus Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nautilus Advisors LLC holds 9,497 shares of BMY stock, worth $417,488. This represents 0.32% of its overall portfolio holdings.
Number of Shares
9,497
Previous 9,646
1.54%
Holding current value
$417,488
Previous $588 Million
25.27%
% of portfolio
0.32%
Previous 0.49%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,674Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.57 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.97 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.75 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.16 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.11 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $93.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...